Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment

Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment

Breast cancer continues to be a prominent worldwide health concern and requires continued investigation into innovative therapeutic approaches. Here, we report the first investigation into the therapeutic efficacy of combining Metformin (MET) and Celecoxib (CXB), both in free and niosomal form, for...

Full description

Bibliographic Details
Main Authors: Haneen A. Basheer, Maram A. Alhusban, Ahlam Zaid Alkilani, Anas Alshishani, Lina Elsalem, Kamyar Afarinkia
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
breast cancer
metformin
celecoxib
niosomes
nanoparticles
Online Access:https://www.mdpi.com/2072-6694/15/20/5004

Internet

https://www.mdpi.com/2072-6694/15/20/5004

Similar Items